2012 : « Best European Equity earning forecast » according to AQ Research
2009-2011 : « Best European Equity research » according to AQ Research
2011 Fourth Quarter : « Best European Equity research » according to AQ Research
2011 Third Quarter : « Best European Equity research » according to AQ Research
2011 First Quarter : « Second European Equity research » according to AQ Research
2011 : Nominated « Best equity research of the year » according to The Technical Analyst
2010 Second Quarter : « Best European Equity research » according to AQ Research
2010 First Quarter : « Third European Equity research » according to AQ Research
2010 : Nominated « Best technical Analyst of the year » according to The Technical Analyst
2010 : Nominated « Best equity research of the year » according to The Technical Analyst
2009 Fourth Quarter : « Best European Equity research » according to AQ Research
2009 Third Quarter : « Best European Equity research » according to AQ Research
2009 Second Quarter : « Third European Equity research » according to AQ Research
2009 : Nominated « Best technical Analyst of the year » according to The Technical Analyst
2009 : Nominated « Best equity research of the year » according to The Technical Analyst
09/01/2012
Source : Reuters lire le PDF
Europe's pharmaceutical stocks are ripe for a serious pull-back after an 18 percent jump in six weeks, chartists said on Monday, although the retreat would likely be a short-term correction rather than a change in trend.